CRBP

Corbus Pharmaceuticals Holdings, Inc. · Healthcare · Market cap $42.4M

Insiders sold $2.0M net in the last 90 days ·4 sellers, 1 buyer· 3 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Nov 2, 2026

Insider Buying

$126K

reported purchases (SEC code P)

Insider Selling

$2.7M

reported sales (SEC code S)

Unique Insiders

10

in the rolling window

Latest filing

Nov 2, 2026

Cormorant Asset Management, LP

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 28 SEC Form 4 filings (29 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Nov 2, 2026.

Inside the rolling window, 10 insiders at Corbus Pharmaceuticals Holdings, Inc. reported 3 open-market purchases totaling $126K and 14 open-market sales totaling $2.7M. The most active filer is Chief Business Officer Saxena Nishant C with 3 filings. Insiders have net sold $2.0M over the trailing 6 months. The most recent open-market filing is a sale of 425,000 shares by Insider Cormorant Asset Management, LP, dated Oct 29, 2026, worth $1.7M.

  • Industry:Biotechnology
  • CEO:Yuval Cohen
  • Employees:36
  • HQ:Norwood, MA, US
  • IPO:2014-10-27
Source
Sale$1.7MNov 2SEC ↗
Ben YongFirst filing
Sale$16KSep 15SEC ↗
Purchase$25KAug 12SEC ↗
Cohen YuvalFirst in 6 months
Sale$171KAug 10SEC ↗
Moran Sean F.First in 6 months
Sale$121KAug 10SEC ↗
Kung WinstonFirst filing
Sale$16KJun 11SEC ↗
Altmeyer AnneFirst filing
Sale$19KJun 11SEC ↗
Sale$38KJun 11SEC ↗
Saxena Nishant CFirst filing
Purchase$33KJun 3SEC ↗
Saxena Nishant CFirst filing
Purchase$68KJun 3SEC ↗
Sale$51KMar 4SEC ↗
Moran Sean F.First filing
Sale$37KFeb 18SEC ↗
Cohen YuvalFirst filing
Sale$108KFeb 18SEC ↗
Sale$6KFeb 18SEC ↗
Smethurst DominicFirst filing
Sale$27KFeb 4SEC ↗
Hodgson IanFirst filing
Sale$20KFeb 4SEC ↗
Sale$344KDec 15SEC ↗
Showing 1–17 of 17
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does CRBP have?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 28 SEC Form 4 filings (29 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Nov 2, 2026.

When was the most recent SEC Form 4 filing for CRBP?

The most recent Form 4 filing for CRBP on Tracefour is dated Nov 2, 2026.

Who is the most active insider at CRBP?

The most active SEC Form 4 filer at CRBP in the rolling window is Chief Business Officer Saxena Nishant C, with 3 filings.

What is the net insider flow at CRBP over the last 6 months?

Over the trailing 180 days, insiders at CRBP have net sold $2.0M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at CRBP in the current window?

Inside the rolling window, insiders at CRBP bought $126K and sold $2.7M based on SEC Form 4 filings.

Can I get alerts for CRBP insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Corbus Pharmaceuticals Holdings, Inc. is in the Healthcare sector.